Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Morissette, Mathieu C ^a   Parent, Julie ^a   Milot, Julie ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GRANZYME; PERFORIN;

ARTICLE; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LUNG EMPHYSEMA; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SMOKING; T LYMPHOCYTE;

FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; GRANZYMES; HUMANS; MALE; MIDDLE AGED; PERFORIN; PULMONARY EMPHYSEMA; SMOKING; T-LYMPHOCYTES;

EID: 38449088863     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-62     Document Type: Article

References (32)

1. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS, . on behalf of the GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001, 163:1256-1276. on behalf of the GOLD Scientific Committee.
2. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004, 56(4):515-548. 10.1124/pr.56.4.2, 15602009.
3. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995, 152:1666-1672.
4. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997, 155(3):852-857.
5. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001, 17(5):946-953. 10.1183/09031936.01.17509460, 11488331.
6. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:822-826.
7. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160(2):711-717.
8. Chrysofakis G, Tzanakis N, Kyriakoy D, Tsoumakidou M, Tsiligianni I, Klimathianaki M, Siafakas NM. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004, 125(1):71-76. 10.1378/chest.125.1.71, 14718423.
9. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 2001, 164(9):1712-1717.
10. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002, 121(5 Suppl):127S-130S. 10.1378/chest.121.5_suppl.127S, 12010840.
11. Andersen MH, Schrama D, Thor Straten P, Becker JC. Cytotoxic T cells. J Invest Dermatol 2006, 126(1):32-41. 10.1038/sj.jid.5700001, 16417215.
12. Arnold V, Balkow S, Staats R, Matthys H, Luttmann W, Virchow JC. Increase in perforin-positive peripheral blood lymphocytes in extrinsic and intrinsic asthma. Am J Respir Crit Care Med 2000, 161(1):182-186.
13. Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2005, 52(1):201-211. 10.1002/art.20745, 15641052.
14. Mark LJ, Yoshimura T, David MN. Mycobacterium bovis BCG Vaccination Augments Interleukin-8 mRNA Expression and Protein Production in Guinea Pig Alveolar Macrophages Infected with Mycobacterium tuberculosis. Infect Immun 2002, 70(10):5471-5478. 128323, 12228272, 10.1128/IAI.70.10.5471-5478.2002.
15. Bas A, Forsberg G, Hammarstrom S, Hammarstrom ML. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol 2004, 59(6):566-573. 10.1111/j.0300-9475.2004.01440.x, 15182252.
16. Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003, 15(31(24)):e154.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
18. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive Protein as a Predictor of Prognosis in COPD. Am J Respir Crit Care Med 2007, 175(3):250-5. 10.1164/rccm.200605-713OC, 17053205.
19. Kim WD, Kim WS, Koh Y, Lee SD, Lim CM, Kim DS, Cho YJ. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest 2002, 122(2):437-444. 10.1378/chest.122.2.437, 12171814.
20. Glader P, von Wachenfeldt K, Lofdahl CG. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers. Respir Med 2006, 100(6):1088-1093. 10.1016/j.rmed.2005.09.025, 16246539.
21. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999, 103:458-462. 10.1016/S0091-6749(99)70471-9, 10069880.
22. Koch A, Gaczkowski M, Sturton G, Staib P, Schinkothe T, Klein E, Rubbert A, Bacon K, Wassermann K, Erdmann E. Modification of surface antigens in blood CD8+-T-lymphocytes in COPD - effects of smoking. Eur Respir J 2007, 29(1):42-50. 10.1183/09031936.00133205, 17050556.
23. Hodge S, Hodge G, Nairn J, Holmes M, Reynolds PN. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD 2006, 3(4):179-87.
24. Arnold V, Balkow S, Staats R, Matthys H, Luttmann W, Virchow JC. Increase in perforin-positive peripheral blood lymphocytes in extrinsic and intrinsic asthma. Am J Respir Crit Care Med 2000, 161(1):182-6.
25. Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, LeBlanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003, 124:83-89. 10.1378/chest.124.1.83, 12853506.
26. Calikoglu M, Sahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, Atik U. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration 2004, 71(1):45-50. 10.1159/000075648, 14872110.
27. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994, 150:1453-1455.
28. Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agusti AG. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J 2005, 25(4):647-652. 10.1183/09031936.05.00062304, 15802338.
29. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 2002, 283(4):L867-873.
30. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002, 26(5):602-609.
31. Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, Sinigaglia F, Fabbri LM. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165(10):1404-1409. 10.1164/rccm.2107139, 12016104.
32. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004, 1(1):e8. 523885, 15526056, 10.1371/journal.pmed.0010008.